Investigational Site Number 840004

San Francisco, California 94143

0 studies enrolling now · 3 studies all time

What they study most

Hematopoietic Neoplasm, Plasma Cell Myeloma

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients — Completed
• A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma — Completed